SCHEMBL19863531

SCHEMBL19863531

c1ccc(-c2ccc(-n3c4ccccc4c4cc5c(cc43)c3ccccc3n5-c3ccc(-c4ccc5c6ccccc6n(-c6ccccc6)c5c4)cc3)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.60
KDM4E B2RXH2 1/20 0.60
ATM Q13315 1/20 0.60
HDAC4 P56524 1/20 0.44
KMT2A Q03164 3/20 0.42
IL1R1 P14778 1/20 0.42
MEN1 O00255 2/20 0.41
MAPT P10636 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HTT P42858 1/20 0.41
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
AVPR1A P37288 1/20 0.40
TSPO P30536 1/20 0.38
MAOB P27338 1/20 0.36
HSP90AA1 P07900 1/20 0.36
PTPN1 P18031 2/20 0.36
KHK P50053 1/20 0.36
MAPK8 P45983 1/20 0.36
ESR1 P03372 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27424098 1.00 L3MBTL1 (0.60) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL23008249 1.00 L3MBTL1 (0.60) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL18505028 0.98 L3MBTL1 (0.62) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL15763779 0.98 L3MBTL1 (0.62) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL23008263 0.98 L3MBTL1 (0.57) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL19769555 0.98 L3MBTL1 (0.62) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL19797680 0.98 L3MBTL1 (0.62) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL15850636 0.97 L3MBTL1 (0.64) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL21578499 0.97 L3MBTL1 (0.64) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL12117338 0.95 L3MBTL1 (0.55) L3MBTL1KDM4EATMHDAC4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10600971-B2 Composition for organic optoelectric device and organic optoelectric device and display device SAMSUNG SDI CO., LTD. (KR) 2020-03-24 US disclosed
US-20180047916-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-02-15 US disclosed
US-20180047916-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10600971-B2 Composition for organic optoelectric device and organic optoelectric device and display device OXER1, OR10J3, OR51E2 L3MBTL1 4752/4885KDM4E 4718/4885ATM 4443/4885
US-20180047916-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE OXER1, OR10J3, OR51E2 L3MBTL1 4752/4885KDM4E 4718/4885ATM 4443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.